IOBT Bounces at Key Support—But Can It Defy Liquidation Odds?

Why is IOBT stock moving today?

IO Biotech (IOBT) stock news has brought sharp focus to the name recently after it filed for Chapter 7 bankruptcy in U.S. Bankruptcy Court for Delaware on March 31, 2026, effectively ceasing operations and moving into liquidation. The regulatory filing is a hard event, with the CEO and CFO also being terminated at the same time, reinforcing the dire fundamentals. However, in post-market trading, IOBT is up 23.96% from $0.048 to $0.0595, with volume confirming the price action strongly. This bounce is happening at a critical support level near $0.048, with RSI hitting 22, which is firmly in oversold territory. The technical structure suggests a potential short-term reversal, even if the broader trend remains bearish.

That said, the move lacks a clear catalyst beyond the technical setup. The company is in liquidation and not expected to return to business, meaning any move higher would be speculative and likely driven by momentum traders or market structure players looking for a bounce. The current price is still far below key moving averages, which continues to reflect the overarching bearish trend. The move should be treated with caution, especially given the regulatory backdrop and the low-probability nature of a turnaround.

What is the most credible trade idea from here?

IOBT is testing a key support level with strong volume and an oversold RSI. This creates a potential pullback entry opportunity for short-term traders, but it's important to note that the broader bearish trend remains intact. The stock has been in a strong downtrend with MA20 and MA50 both trending lower. A successful bounce from $0.048 would need to be confirmed by a close above that level and a follow-through in volume. A close above the MA20 at $0.1854 would be a stronger confirmation signal, though that is a steep target from the current price.

In practice, the most credible trade is to look for a retest of the $0.048 support zone with volume confirmation and a move above that level as a potential short-term reversal trigger. A bullish breakout above $0.10 would be a stronger signal of a temporary shift in sentiment, though it would not necessarily reverse the bearish trend. The ATR of $0.033 suggests there is enough volatility to allow for a bounce but not enough to overcome the structural bearishness of the trend.

The risk is clear: a breakdown below $0.048 with strong volume and RSI falling below 15 would invalidate the pullback thesis. The bear case remains strong, and a failed bounce could accelerate the downtrend.

What should investors watch next over the coming sessions?

Over the next one to two sessions, the key focus should be on whether IOBT can hold above $0.048 and generate follow-through volume. A close above that level with a rebound in RSI would strengthen the case for a short-term bounce. On the flip side, a failure to hold $0.048 or a breakdown below $0.035 would increase the odds of a deeper correction.

Crucially, traders should also monitor volume patterns. Relative volume has been above average, and a sustained volume expansion would support the bullish case. However, if volume begins to taper off as the price rises, that would be a warning sign that the move is running out of steam.

By contrast, a close below MA20 ($0.1854) over multiple sessions would suggest that the bearish trend is still in control and that the current bounce is just a temporary reprieve. A sustained move above that level would be a stronger signal that the trend is shifting.

In the broader context, the post-market rally in the Nasdaq futures is a positive backdrop, offering some support for small-cap biotech names like IOBT. But since IOBT operates in a speculative sector and is currently in liquidation, the macro context alone is unlikely to drive a sustained move higher.

The bottom line: IOBT is in a high-risk, high-reward setup. A successful bounce from $0.048 could offer a short-term trade, but the bearish trend is still in control. Investors should approach this with caution and clearly define their exit and invalidation levels.

Why is the stock moving today?

IOBT support and resistance levels are currently at $0.048 (nearest support) and $0.1854 (nearest resistance). The stock is in the process of testing these levels in a volatile market environment. Given the strong volume confirmation and the oversold RSI, the current move could be a short-term reversal, but the fundamentals remain bearish. Traders should watch for a clear breakout or breakdown over the next couple of sessions to determine the next phase of the move.